Fecal microbiota transplant has become more acceptable as a therapeutic for recurrent Clostridium difficile infection. The FDA has an enforcement discretion policy for practitioner's performing this therapy, which includes informed consent for this experimental treatment. This manuscript describes a typical procedure that can be followed that includes the important aspects of this preparation and treatment.
Keywords: CDI; Clostridium difficile; FMT; fecal microbiota transplant; stool.
Copyright© by the American Society for Clinical Pathology (ASCP).